Shire Nabs Advanced BioHealing Before It Can Test the Public Waters
This article was originally published in The Pink Sheet Daily
Executive Summary
Diversifying further, the specialty outfit will spend $750 million in cash for the regenerative medicine firm and its marketed wound-healing cell therapy product.